Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute of Human Genetics, |
RCV002284585 | SCV002574001 | pathogenic | Cystic fibrosis | 2023-07-26 | criteria provided, single submitter | curation | This variant was classified based on the report of 1 patient with a clinically confirmed diagnosis of cystic fibrosis in the context of re-classifying variants in the German Cystic Fibrosis Registry (Muko e.V.). Patients have not been seen personally, but only reports were evaluated. Criteria applied:PVS1, PM2_SUP, PP4 |
Ambry Genetics | RCV002284585 | SCV003911057 | pathogenic | Cystic fibrosis | 2023-01-23 | criteria provided, single submitter | clinical testing | The c.777delT pathogenic mutation (also known as p.V260*), located in coding exon 7 of the CFTR gene, results from a deletion of one nucleotide at nucleotide position 777. This changes the amino acid from a valine to a stop codon within coding exon 7. This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |
Baylor Genetics | RCV004572122 | SCV005057433 | pathogenic | Bronchiectasis with or without elevated sweat chloride 1 | 2024-02-19 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005032220 | SCV005673296 | likely pathogenic | Bronchiectasis with or without elevated sweat chloride 1; Cystic fibrosis; Hereditary pancreatitis; Congenital bilateral aplasia of vas deferens from CFTR mutation | 2024-01-08 | criteria provided, single submitter | clinical testing |